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Abstract : The supportive therapeutic use on Dengue Hemorrhagic Fever (DHF) is currently a
trend in society, while empirical data regarding the safety of its use is not yet complete, so the
researchers wanted to see how the effects of the use of red angkak to the patients (DHF).
The aim of research was to determine the effect of the use of red angkak to increase platelets in
patients with DHF.
The research method was a quasi-experimental, samples were consisted of 15 people as
experimentalal group and 15 people as the control group, they also consumed 500 cc / day for 7
days while assessing changes in platelets.
Data were obtained by paired student T test, the results of the research found changes in the
levels of platelets before and after administration of red angkak fluid  with average of the
value before  (92666.67) to platelets 1 became (112,600.00) with an average increase  of 19933
( 21.51%)with p: 0.005. Furthermore, the average change from its number before to
platelets 2 was (127,000.00) with an average increase of a prior of 34 333 (37.04%) with
p: 0.000, and the average change from its number before to become a platelet 3 was (145
466, 67) with an average increase before amounted to 52 800 (56.97%)  with p:0.000, and the
last change in the average of prior to becoming platelets 4 was
(154,833.33) with an average increase before amounted to 63 166 (68, 16%) with  p:0.002.
This indicated a significant effect of fluid therapy with red angkak fluid.
The conclusion showed the use of red Angkak as supportive therapy to patients with DHF can
be continued because in addition it was not interfere with the principle of therapy that has been
done, but it can also help speed up the return of hemodynamics.
Suggestions of this research is requirements for clinical trial or non clinical trials to see more
accurate aspect that react chemically in the body.
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Introduction
The incidence of dengue worldwide reached 390 million people infected each year generally exposed to
the tropical regions. (1), it is exacerbated by endothelial damage causing leakage of plasma which can lead to
hypovolemic shock (2) and other complications are more severe, including hemorrhage (2).
Results of invitro studies showed that lovastatin can reduce dengue because it can stabilize vascular
endothelial dysfunction and statins may modulate dengue vaskulopathy, so that statin may  be  able  to  have
antiviral properties. (3, 4)
Angkak product was made by fermentation of rice by Monascus Purpureus. The product of this dye
color has been widely used in Asian countries, especially Japan, China, Taiwan, Thailand and the Philippines to
provide an attractive red color in certain fermented products, such as red wine, cheese, red soybeans and fish
sauce. ( 5, 6)
One of the biochemical content of red angkak is lovastatin which  can  increase  platelets  and  helps
fighting the dengue virus. (7) Lovastatin is also known as cholesterol-lowering agents. In the mechanism of
cholesterol-lowering, lovastatin lowers bad cholesterol (LDL) with its oxidation. LDL oxidized with and
megakaryocyte chemotactic protein - 1 stimulate the regeneration of the endothelium room and turn each into
macrophages and activated platelets. These macrophages and platelets fight the dengue virus and then eliminate
it. (7)
In addition to increase the number of platelets and the function of macrophages, angkak with its
lovastatin can also donate ubiquinone and heme- A which are important to increase cell energy and repair of red
blood cells. Both of these are very important in support the healing process dengue fever. (8)
Material and Methods
The research design
Used in this  study was Quasy-  experimental,  where this  draft  seeks to reveal  a  causal  relationship by
engaged the control group and the experimentalal group. In this design, the experimentalal group was treated
while the control group was not given treatment.
This research was conducted
At RSUP.DR. Wahidin Sudirohusodo in Lontara IV Care Unit. The study population was all patients
with dengue hemorrhagic fever that treated within a specified timeframe. Samples taken are dengue patients
treated in Lontara IV who were diagnosed by stage II DBD appropriated diagnostic workup.
Research procedures,
A diagnostic test was done to help diagnose dengue positive. Identify the type of treatment given
patients for example drug therapy, the type of fluid and the use of alternative therapies angkak type liquid red
substance that has been extracted from red rice that had been boiled and the last was following the development
of  both  the  patient  and  the  general  state  of  platelets  change  results.  Data  were  tabulated  according  to  age,
gender, type of medication, type of fluid, and the use of red angkak substance.
Data Analysis.
Data were analyzed statistically using the Paired t Test.
Result and Discussion.
From  the  results  of  a  study  of  30  patients  with  DHF  Grade  II  as  research  subjects  (15  control  -  15
experimental), found significant difference in platelet value changes faster in the experimentalal group
compared with the control group (graph 1). Where it was consistent with the results of interventions that have
been performed by administering fluids to drink red substance angkak 500  cc  per  day  in  the  group  treated
subjects during follow up showed an improvement of platelets results supported the clinical picture.
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While the results of statistical analysis using paired T test showed the control group of platelets pre
value to the platelets of 4 decreased from day 1 to day 5. This indicated that in every patient given parenteral
fluid therapy and medications were the same, the level of hemodynamic function returning of the body was
aided by the presence of some chemical content of the red substance at the molecular level angkak included
lovastatin. This suggested a significant effect with red angkak fluid therapy in patients with DHF Grade II with
p <0.005. From these data, it can be said that the red substance Angkak can help speed up the process of
improvement of circulation mainly on the improvement of platelets in patients with dengue fever dengue.Tabel
1-2.
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Table 1 Distribution Change Average - Average Value Platelets in the Experimental Group
EnhancementExperimental
Group
N Mean
Deviation
Standard
Average %
Paired
T Test
(p)
Platelet before
and after (Plt 1)
15 92666,67
112600,00
29310,32
38433,24
19933  21,51 0,005
Platelet before
and after (Plt 2)
15 92666,67
127000,00
29310,32
38827,45
34333 37,04 0,000
Platelet before
and after (Plt 4)
15 92666,67
145466,67
29310,32
38862,15
52800 56,97 0,000
Platelet before
and after (Plt 4)
15 92666,67
154833,33
29310,32
46700,82
63166 68,16 0,002
Primary Data Sources
Table 2 Distribution Change Average - Average Value Platelets in the Control Group
EnhancementControl Group N Mean Deviation
Standard
Average %
Paired T
Test
(p)
Platelet before
and after (Plt 1)
15 107133,33
88400,00
33570,53
36531,39
-18733,3 17,48 0,002
Platelet before
and after (Plt 2)
15 107133,33
83333,33
33570,53
30576,99
-23800,0 22,21 0,015
Platelet before
and after (Plt 3)
15 107133,33
95333,33
33570,53
36147,84
-11800,0 11,00 0,280
Platelet before
and after (Plt 4)
15 107133,33
103533,33
33570,53
41716,50
-3600,0 3,36 0,784
Primary Data Sources
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The results of this study were supported by research and were conducted by Lin CP et al 2011, it
showed the red rice (Monascus purpureus) was able to stimulate the reduction in TNF-α adhesiveness to the
endothelium that trigger inflammation and leakage endothelial aggravating conditions in DHF, and
downregulating intracellular ROS, NF-kB activation. (7, 9)
In addition to increase the number of platelets and the function of macrophages, angkak with its
lovastatin can also donate ubiquinone and heme- A which were important in increase cell energy and repair of
cells - red blood cells. Both of these were very important in support the healing process of dengue fever. This
study was also able to confirm the results that researchers got from the dengue hemorrhagic fever patients stage
II indicating faster platelets improvement in experimenal patients compared with patients who were not given
the treatment. (3, 4, 10)
Based on the research resulted by Whitehorn J et al, 2012, that the development of dengue fever
therapies that can reduce the risk of the death from this disease have made substantial progress in global health.
It was through the beneficial effect of lovastatin on the endothelium of work, a better safety profile and lower
cost made lovastatin as an attractive therapy in dengue hemorrhagic fever. (11-13)
Conclusion
The use of boiled red angkak water (Monascus purpureus) can increase platelets in patients with DHF
grade 2.
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